Documente Academic
Documente Profesional
Documente Cultură
Some concern about recently published nonpatient data, plus the fact that some re-
cords in the published sample of 600 nonpatients (Exner, 2001) were collected more
than 20 years ago, prompted the initiation of a project to develop a new nonpatient
sample. In this article, findings are presented for the first 175 participants tested in the
new project. It is noted that the data from the new project are quite similar to those for
the sample of 600. Results suggest that the similarities between the data sets supports
the notion that the published sample is probably representative and provides a reason-
able basis from which to identify response rates and the proportions of nonpatients ex-
pected to fall in, or outside of, established parameters for various ratios and other
structural indexes.
they provide for developing some general interpretive postulates using the devia-
tion principle, which focuses on findings different than expected.
Almost any normative samples will have limitations, and those formed to create
tables for use with the Comprehensive System are no exceptions. The nonpatient
records used to create those samples were collected over a period of more than 10
years (19731986). As the number of available records increased, the tables were
revised three times as various attempts to stratify the sample ensued (Exner, 1978,
1986, 1990; Exner, Weiner, & Schuyler, 1976). A major revision occurred in 1990
because of findings indicating that brief recordsthat is, those containing less
than 14 answersare likely to be invalid (Exner, 1988). Those findings made it
necessary to discard all records with less than 14 answers that had been included in
previously developed samples. By that time, the pool of nonpatient protocols num-
bered more than 1,100 records, and the revised sampleselected using the stratifi-
cation criteria of sex, geographic area, and socioeconomic levelincluded
findings for 700 persons.
When the sample of 700 was selected, using the stratification criteria, more than
200 duplicate records were inadvertently included. They were detected in 1999,
and the duplicates were removed from the sample. The majority have been replaced
with records from the nonpatient pool that had not been used previously and that in-
cluded demographic features that would not alter the stratification of the sample
significantly. The current published sample consists of data from the protocols of
600 adult nonpatients (Exner, 2001). The sample represents 300 males and 300 fe-
males, with 120 participants from each of five geographic areasNortheast, South,
Midwest, Southwest, and Westand is partially stratified for socioeconomic level.
Attempts were made to equalize the number of males and females from each region
but that was not always possible. Thus, the number of males and females are nearly
equal for four regions, but the southwest group includes 72 females and 48 males,
whereas the midwest group contains 74 males and 46 females.
The 600 protocols were collected by 42 examiners working within the constraints
of problems created by participant recruitment and sample sizes. No examiner con-
tributed more than 25 protocols to this sample. All of the participants were, in one
sense or another, volunteers. None had special reasons to be examined, and none
had any significant psychiatric history. About 17% (101) of the participants gave
histories that included having eight or fewer contacts (the maximum permitted for
NEW NONPATIENT SAMPLE 393
Among the issues that confront those who use normative data as a guide for inter-
pretation are the extent to which the data are truly representative of nonpatients and
whether the sample has been cross-validated. Recently, Shaffer, Erdberg, and
Haroian (1999) used graduate students to test 123 volunteer nonpatients. Many of
their findings are very similar to those in the published sample of 600 nonpatients.
However, there are also some striking differences. The mean for R is 20.83, with a
median of 18 and a mode of 14, as contrasted with a mean R of 22.32, with a median
of 22 and a mode of 23 for the sample of 600. Lambda values greater than 0.99 oc-
curred for 51 (41%) of the participants in the Shaffer et el. sample as compared to 58
(10%) in the sample of 600. Some other substantial differences between the two
samples include means of .48 versus .67 for the Afr, .78 versus .92 for the XA%,
and .82 versus .94 for the WDA%.
The differences between the samples for the XA% and WDA% reflect differ-
ences for the other variables related to form use. The means are .51 versus .77 for
the X + %, .28 versus .15 for the Xu%, and .21 versus .07 for the X %. Only 44
(36%) of persons in the Shaffer et al. sample gave at least one texture answer,
whereas 490 (82%) of those in the larger sample did so. Nearly 30% of the persons
in the Shaffer et al. sample gave at least one reflection response as contrasted with
only 8% in the sample of 600. In addition, the means for WSumC, EA, and es in the
Shaffer et al. sample are about 2 points lower than those for the sample of 600. In-
terestingly, when the Shaffer et al. sample was increased to include 283
nonpatients (Shaffer & Erdberg, 2001), only modest changes in the values for
these variables were noted.
394 EXNER
The differences noted between the Shaffer et al. data and those in the current
Comprehensive System sample of 600, plus the fact that some of those data were
collected more than 20 years ago, prompted the Research Council of Rorschach
Workshops1 to recommend the collection of a new nonpatient sample to ascertain
the ultility of the published sample.
This project was initiated during the fall of 1999, using essentially the same design
and exclusionary criteria as for the original project during the period from 1973 to
1986. There are three differences in this model. About 75% of the nonpatients
tested between 1973 and 1981 were recruited by persons employed primarily to so-
licit participants for various investigations. In this project, examiners recruited
their own participants through organizations and businesses using essentially the
same procedures previously used by recruiters, including a slightly modified ver-
sion of the solicitation letter (see Appendix). A second difference concerns pre-
scribed medications or illegal drug use. Questions concerning these issues were not
asked of persons tested between 1973 and 1986. However, both seem more impor-
tant at this time. Anyone volunteering was tested, but the records of those having a
prolonged or significant history involving prescribed psychotropics (N = 3) or ad-
mitting to regular use of illegal drugs (N = 0) were excluded from the sample. A
third difference concerns the financial structure. Persons tested in the original pro-
ject were not paid. In this project, volunteers also were not paid, but as a form of en-
ticement, a $25 donation was paid in the name of the participant to any recognized
charity that the person selects.
More than 10 years were required to obtain the pool of more than 1,100 records
from which to form the stratified sample representing 600 nonpatients. This pro-
ject is proceeding at about the same pace. During the first 2 years since the project
was initiated, nearly 200 participants, from 14 states2, have been tested by 13 expe-
rienced examiners. Each examiner codes the records that he or she has collected
and the coding is reviewed for errors in the central office of Rorschach Workshops
at the time it is computer entered. In addition, every fourth protocol is recoded by
the author, and percentages of correct agreement are recorded as a tactic to review
scoring accuracy and provide feedback to examiners when relevant.
1Research Council membership at the time of the recommendation included Thomas Boll, Philip
Erdberg, John Exner, Mark Hilsenroth, Gregory Meyer, William Perry, and Donald Viglione.
2States represented in this sample include Alaska, California, Georgia, Iowa, Kentucky, Maryland,
New Hampshire, New Jersey, North Carolina, Tennessee, Texas, Virginia, Vermont, and West
Virginia.
NEW NONPATIENT SAMPLE 395
RESULTS
Descriptive statistics for the various codings and some calculated variables for the
first 175 persons included in this project are shown in Table 1. Table 2 includes
some demography information concerning the group, plus frequency data for vari-
ous cutoff points related to some general interpretive principles.
Table 3 includes data for 12 variables from the published sample of 600
nonpatients and those for the first 175 records collected in this project. These are
the variables described earlier for which there were noticably discrepant findings
between the Shaffer et al. sample and the sample of 600 participants. The large
samples sizes yielded very large degrees of freedom when t tests were used to
study differences between the means, and resulting p values can be misleading or
misinterpreted. Thus, it seems more appropriate to evaluate the differences by us-
ing the values for Cohens d and Pearson correlations to provide information about
effect sizes (Cohen, 1992). These are also included in Table 3.
The data for the sample of 600 and the new sample of 175 are reasonably simi-
lar for all 12 variables. The mean for the X + % in the new sample is .09 lower, the
mean for the Xu% is .06 higher, and the mean for the X % is .03 higher than in the
sample of 600. Using Cohens classification for effect sizes, the first two indicate a
large effect, whereas the third represents a medium effect. A medium effect is also
indicated for the XA% and WDA%. These may represent true differences between
the two samples. However, as suggested by Meyer (2001), differences in pre- and
post-1990 data sets for Form Quality scores may simply reflect the revisions and
expansions of the Form Quality table during the 15 year period after the first ver-
sion of the table was published. Regardless, the differences between the two
groups for Form Quality variables are rather modest and do not suggest the need
for any change in the basic rules of interpretation. In fact, the data for all of the
variables shown in Table 1 indicate reasonable similarities with the data published
for the sample of 600.
There are some differences worth noting in some of the frequency data shown
in Table 2. As noted in Table 3, even though the mean values for Lambda are es-
396
TABLE 1
Descriptive Statistics for 175 Nonpatient Adults
Age 35.53 13.23 19.00 86.00 175 32.00 24.00 1.26 1.70
Years of education 14.15 1.73 10.00 20.00 175 14.00 14.00 0.61 0.35
R 22.98 5.51 14.00 51.00 175 22.00 21.00 1.65 5.14
W 9.20 4.23 3.00 37.00 175 8.00 8.00 2.35 10.59
D 12.45 5.11 0.00 32.00 173 13.00 14.00 0.19 1.31
Dd 1.33 [1.47] 0.00 8.00 116 1.00 0.00 1.74 4.31
S 2.23 [1.96] 0.00 17.00 162 2.00 1.00 3.36 19.57
DQ+ 8.33 3.13 1.00 21.00 175 8.00 9.00 0.73 2.05
DQo 13.93 4.59 4.00 36.00 175 14.00 14.00 1.02 3.57
DQv 0.41 [0.70] 0.00 3.00 52 0.00 0.00 1.74 2.47
DQv/+ 0.32 [0.70] 0.00 6.00 44 0.00 0.00 4.04 26.03
FQx+ 0.47 [0.87] 0.00 5.00 52 0.00 0.00 2.27 5.92
FQxo 14.95 3.39 8.00 29.00 175 15.00 16.00 0.33 1.25
FQxu 5.03 2.77 1.00 17.00 175 5.00 3.00 1.64 4.25
FQx 2.33 1.73 0.00 12.00 163 2.00 2.00 2.09 7.51
FQxNone 0.20 [0.49] 0.00 3.00 29 0.00 0.00 2.76 8.54
MQ+ 0.31 [0.62] 0.00 3.00 42 0.00 0.00 1.94 3.15
MQo 3.86 1.88 1.00 9.00 175 4.00 3.00 0.36 0.60
MQu 0.41 0.77 0.00 5.00 49 0.00 0.00 2.46 8.00
MQ 0.17 [0.44] 0.00 2.00 24 0.00 0.00 2.75 7.10
MQNone 0.00 [0.00] 0.00 0.00 0 0.00 0.00
SQual 0.53 [0.82] 0.00 4.00 67 0.00 0.00 1.76 3.12
M 4.75 2.19 1.00 11.00 175 5.00 3.00 0.37 0.11
FM 3.86 1.98 0.00 10.00 169 4.00 4.00 0.42 0.53
m 1.47 1.35 0.00 10.00 138 1.00 1.00 2.08 8.79
FC 2.81 1.79 0.00 8.00 161 2.00 2.00 0.60 0.11
CF 2.93 1.89 0.00 12.00 165 3.00 2.00 1.49 4.92
C 0.23 [0.54] 0.00 3.00 33 0.00 0.00 2.70 8.24
Cn 0.00 [0.00] 0.00 0.00 0 0.00 0.00
Sum Color 5.97 2.68 0.00 14.00 174 6.00 5.00 0.54 0.42
WSum C 4.69 2.27 0.00 15.00 174 4.50 4.00 1.09 2.87
Sum C' 1.64 [1.31] 0.00 8.00 146 1.00 1.00 1.26 2.90
Sum T 0.90 [0.64] 0.00 2.00 130 1.00 1.00 0.08 0.52
Sum V 0.37 [0.82] 0.00 5.00 42 0.00 0.00 3.23 13.06
Sum Y 0.82 [1.06] 0.00 7.00 95 1.00 0.00 2.44 9.60
Sum Shading 3.72 2.27 0.00 14.00 173 3.00 3.00 1.67 4.21
Fr + rF 0.26 [0.81] 0.00 7.00 26 0.00 0.00 4.81 30.77
FD 1.42 [1.13] 0.00 5.00 136 1.00 1.00 0.67 0.12
F 7.97 3.51 1.00 23.00 175 7.00 7.00 0.96 2.28
(2) 8.51 2.69 2.00 21.00 175 8.00 9.00 0.66 2.50
3r + (2)/R 0.41 0.11 0.13 0.87 175 0.39 0.38 0.93 2.84
Lambda 0.61 0.38 0.06 2.33 175 0.50 0.50 1.43 2.65
FM + m 5.33 2.55 0.00 20.00 174 5.00 6.00 1.34 6.30
EA 9.43 3.39 2.00 24.00 175 9.50 8.00 0.82 2.08
es 9.05 3.99 2.00 34.00 175 9.00 8.00 1.98 9.16
D Score 0.03 0.90 3.00 3.00 60 0.00 0.00 0.45 3.83
AdjD 0.29 0.89 3.00 3.00 73 0.00 0.00 0.05 2.71
a (active) 6.54 2.84 0.00 18.00 174 6.00 6.00 0.44 1.07
p (passive) 3.57 2.09 0.00 13.00 169 3.00 3.00 0.98 2.23
Ma 2.86 1.66 0.00 8.00 164 3.00 3.00 0.50 0.32
Mp 1.90 1.33 0.00 7.00 154 2.00 2.00 0.99 1.84
Intellect 2.26 2.08 0.00 12.00 141 2.00 1.00 1.40 2.83
Zf 13.34 4.55 2.00 41.00 175 12.00 12.00 2.04 8.62
Zd 0.47 3.88 13.50 12.00 164 0.50 0.50 0.16 1.30
Blends 5.55 2.72 0.00 18.00 172 5.00 4.00 0.54 1.58
Blends/R 0.24 0.11 0.00 0.53 172 0.24 0.24 0.00 0.30
(continued)
397
TABLE 1 (Continued)
398
Col-Shd Blends 0.65 [0.91] 0.00 6.00 82 0.00 0.00 2.43 9.42
Afr 0.61 0.18 0.21 1.26 175 0.63 0.67 0.19 0.35
Populars 6.30 1.58 1.00 11.00 175 6.00 7.00 0.32 1.02
XA% 0.89 0.07 0.69 1.00 175 0.90 0.90 0.75 0.49
WDA% 0.91 0.06 0.69 1.00 175 0.92 0.95 0.98 1.29
X+% 0.68 0.11 0.35 0.95 175 0.69 0.67 0.55 0.25
X% 0.10 0.06 0.00 0.31 163 0.10 0.05 0.77 0.72
Xu% 0.21 0.09 0.05 0.49 175 0.21 0.16 0.50 0.07
Isolate/R 0.21 0.10 0.00 0.60 171 0.20 0.16 0.56 1.11
H 3.12 1.71 0.00 10.00 172 3.00 3.00 0.82 1.00
(H) 1.39 1.09 0.00 6.00 137 1.00 1.00 0.86 1.33
HD 1.06 [1.03] 0.00 5.00 116 1.00 1.00 1.07 1.46
(Hd) 0.59 [0.87] 0.00 4.00 68 0.00 0.00 1.44 1.52
Hx 0.14 [0.50] 0.00 4.00 18 0.00 0.00 4.75 27.45
H + (H) + Hd + (Hd) 6.15 2.53 0.00 18.00 174 6.00 7.00 0.96 3.05
A 8.05 2.65 3.00 25.00 175 8.00 6.00 1.78 8.80
(A) 0.32 [0.58] 0.00 3.00 47 0.00 0.00 1.82 3.20
Ad 2.70 [1.57] 0.00 9.00 169 3.00 2.00 0.79 0.99
(Ad) 0.14 [0.40] 0.00 2.00 22 0.00 0.00 2.85 7.96
An 0.87 [1.12] 0.00 7.00 98 1.00 0.00 2.15 6.67
Art 1.27 1.31 0.00 6.00 112 1.00 0.00 1.09 1.13
Ay 0.59 [0.76] 0.00 4.00 82 0.00 0.00 1.47 2.78
Bl 0.27 [0.55] 0.00 3.00 39 0.00 0.00 2.16 4.79
Bt 2.25 1.54 0.00 6.00 150 2.00 2.00 0.36 0.48
Cg 1.99 1.56 0.00 8.00 143 2.00 2.00 0.92 1.31
Cl 0.22 [0.49] 0.00 2.00 33 0.00 0.00 2.17 4.00
Ex 0.20 [0.51] 0.00 4.00 29 0.00 0.00 3.59 18.27
Fi 0.75 [0.87] 0.00 4.00 95 1.00 0.00 1.36 2.31
Food 0.30 [0.56] 0.00 3.00 45 0.00 0.00 1.90 3.67
Ge 0.09 [0.33] 0.00 2.00 14 0.00 0.00 3.80 15.15
Hh 1.11 0.97 0.00 5.00 123 1.00 1.00 0.72 0.45
Ls 1.04 1.16 0.00 9.00 112 1.00 1.00 2.51 12.88
Na 0.51 [0.89] 0.00 6.00 62 0.00 0.00 2.70 10.50
Sc 1.55 [1.23] 0.00 6.00 143 1.00 1.00 0.97 1.03
Sx 0.18 [0.49] 0.00 3.00 25 0.00 0.00 3.01 9.74
Xy 0.09 [0.29] 0.00 1.00 16 0.00 0.00 2.86 6.25
Idiographic 0.37 [0.61] 0.00 3.00 53 0.00 0.00 1.60 2.19
DV 0.42 [0.71] 0.00 5.00 58 0.00 0.00 2.43 9.62
INCOM 0.72 [0.90] 0.00 4.00 85 0.00 0.00 1.25 1.28
DR 0.82 [0.93] 0.00 7.00 101 1.00 0.00 2.11 10.20
FABCOM 0.43 [0.68] 0.00 3.00 61 0.00 0.00 1.72 3.11
DV2 0.00 [0.00] 0.00 0.00 0 0.00 0.00
INC2 0.03 [0.18] 0.00 1.00 6 0.00 0.00 5.16 24.94
DR2 0.03 [0.18] 0.00 1.00 6 0.00 0.00 5.16 24.94
FAB2 0.06 [0.23] 0.00 1.00 10 0.00 0.00 3.84 12.96
ALOG 0.06 [0.23] 0.00 1.00 10 0.00 0.00 3.84 12.96
CONTAM 0.00 [0.00] 0.00 0.00 0 0.00 0.00
Sum6 Sp Sc 2.58 1.79 0.00 10.00 155 2.00 2.00 0.78 1.09
Lvl 2 Sp Sc 0.13 [0.37] 0.00 2.00 20 0.00 0.00 2.96 8.70
WSum6 7.08 5.35 0.00 28.00 155 6.00 0.00 1.03 1.66
AB 0.20 [0.51] 0.00 3.00 27 0.00 0.00 2.82 8.26
AG 0.94 1.08 0.00 7.00 103 1.00 0.00 1.73 5.45
COP 2.09 1.35 0.00 6.00 157 2.00 2.00 0.54 0.06
CP 0.00 [0.00] 0.00 0.00 0 0.00 0.00
GOODHR 5.13 2.15 0.00 13.00 173 5.00 4.00 0.42 0.68
POORHR 1.97 1.57 0.00 8.00 147 2.00 1.00 1.10 1.56
MOR 0.92 [0.96] 0.00 4.00 103 1.00 0.00 0.84 0.13
PER 0.87 [1.01] 0.00 7.00 101 1.00 0.00 1.95 7.37
PSV 0.10 [0.33] 0.00 2.00 15 0.00 0.00 3.63 13.73
399
Note. Standard deviations shown in brackets indicate that the value is probably unreliable and/or misleading and should not be used to estimate expected
ranges. Ordinarily these variables should not be included in most parametric analyses.
TABLE 2
Demography Data and Frequencies for 36 Variables for Nonpatients
DEMOGRAPHY VARIABLES
MARITAL STATUS AGE RACE
Single . . . . . . . . . . . . . . . . . . . 45 26% 1825 . . . . . . 44 25% White . . . . . . . . . . . . . 150 86%
Lives w/S. . . . . . . . . . . . . . . . . . 6 3% 2635 . . . . . . 56 32% Black . . . . . . . . . . . . . . 14 8%
Married . . . . . . . . . . . . . . . . . . 91 52% 3645 . . . . . . 44 25% Hispanic . . . . . . . . . . . . 10 6%
Separated. . . . . . . . . . . . . . . . . . 6 3% 4655 . . . . . . 15 9% Asian . . . . . . . . . . . . . . . 1 1%
Divorced . . . . . . . . . . . . . . . . . 23 13% 5665 . . . . . . 10 6% Other . . . . . . . . . . . . . . . 0 0%
Widowed . . . . . . . . . . . . . . . . . . 4 2% OVER 65 . . . . 6 3% Unlisted . . . . . . . . . . . . . 0 0%
Unlisted . . . . . . . . . . . . . . . . . . . 0 0%
EDUCATION
SEX Under 12 . . . . . . . . . . . . 2 1%
Male . . . . . . . . . . . . . . . . . . . . 85
49% 12 Years. . . . . . . . . . . . 33 19%
Female. . . . . . . . . . . . . . . . . . . . 0
51% 1315 Years . . . . . . . . 101 58%
16+ Years. . . . . . . . . . . 39 22%
RATIOS, PERCENTAGES AND SPECIAL INDEXES
STYLES FORM QUALITY DEVIATIONS
Introversive . . . . . . . . . . . . . . . 59 34% XA% > .89. . . . . . . . . . 93 53%
Pervasive Introversive. . . . . . . . 8 5% XA% < .70. . . . . . . . . . . 1 1%
Ambitent . . . . . . . . . . . . . . . . . 34 19% WDA% < .85 . . . . . . . . 20 11%
Extratensive. . . . . . . . . . . . . . . 54 31% WDA% < .75 . . . . . . . . . 2 1%
Pervasive Extratensive . . . . . . . 7 4% X + % < .55 . . . . . . . . . 19 11%
Avoidant . . . . . . . . . . . . . . . . . 28 16% Xu% > .20 . . . . . . . . . . 88 50%
X % > .20 . . . . . . . . . 15 9%
D-SCORES X % > .30 . . . . . . . . . . 1 1%
D Score > 0 . . . . . . . . . . . . . . . 34 19%
D Score = 0 . . . . . . . . . . . . . . 115 66% FC:CF + C RATIO
D Score < 0 . . . . . . . . . . . . . . . 26 15% FC > (CF + C) + 2 . . . . 25 14%
D Score < 1 . . . . . . . . . . . . . . . 7 4% FC > (CF + C) + 1 . . . . 40 23%
(CF + C) > FC + 1 . . . . 53 30%
Adj D Score > 0 . . . . . . . . . . . 57 33% (CF + C) > FC + 2 . . . . 29 17%
Adj D Score = 0 . . . . . . . . . . 102 58%
Adj D Score < 0 . . . . . . . . . . . 16 9%
Adj D Score < 1 . . . . . . . . . . . 5 3%
S-Constellation Positive . . 0 0%
400
NEW NONPATIENT SAMPLE 401
TABLE 2 (Continued)
MISCELLANEOUS VARIABLES
R < 17 . . . . . . . . . . . . . . . . . . . 12 7% (2AB + Art + Ay) > 5. . 13 7%
R > 27 . . . . . . . . . . . . . . . . . . . 25 14% Populars < 4. . . . . . . . . . 8 5%
DQv > . . . . . . . . . . . . . . . . . . . 23 2% Populars > 7. . . . . . . . . 31 18%
S > 2 . . . . . . . . . . . . . . . . . . . . 58 33% COP = 0 . . . . . . . . . . . . 18 10%
Sum T = 0 . . . . . . . . . . . . . . . . 45 26% COP > 2 . . . . . . . . . . . . 61 35%
Sum T > 1 . . . . . . . . . . . . . . . . 27 15% AG = 0 . . . . . . . . . . . . . 72 41%
3r + (2)/R < .33 . . . . . . . . . . . . 34 19% AG > 2 . . . . . . . . . . . . . 12 7%
3r + (2)/R > .44 . . . . . . . . . . . . 53 30% MOR > 2 . . . . . . . . . . . 11 6%
Fr + rF > 0. . . . . . . . . . . . . . . . 26 15% Level 2 Sp Sc > 0. . . . . 20 11%
PureC > 0 . . . . . . . . . . . . . . . . 33 19% GHR > PHR. . . . . . . . 152 87%
PureC > 1 . . . . . . . . . . . . . . . . . 6 3% Pure H < 2 . . . . . . . . . . 29 17%
Afr < .40 . . . . . . . . . . . . . . . . . 19 11% Pure H = 0 . . . . . . . . . . . 3 2%
Afr < .50 . . . . . . . . . . . . . . . . . 44 25% p > a + 1. . . . . . . . . . . . 12 7%
(FM + m) < Sum Shading. . . . . 30 17% Mp > Ma . . . . . . . . . . . 41 23%
Note. N = 175.
sentially the same, only 58 (10%) of those in the sample of 600 have Lambda val-
ues of 1.0 or greater, whereas the new sample includes 28 (16%) persons who have
high Lambda values (d = .17, r = .08). In addition, the sample of 600 includes 10%
who gave Pure C responses, as contrasted with 19% of the new sample (d = .22, r =
.11). Only 5% of the persons in the sample of 600 have positive DEPI values,
whereas 17% of those in the new sample have such values (d =.17, r = .08). Like-
wise, 66% of those in the sample of 600 gave at least one more FC response than
the composite of CF + C. In the new sample, only 37% did so (d = .48, r =.23). Al-
though these differences are interesting, none cause concern about the basic princi-
ples of interpretation.
DISCUSSION
Although the new sample does not have the broad geographic distribution or the
attempted stratification for socioeconomic status that is represented in the larger
sample, the comparative similarities between the two groups tend to support the
notion that published data for the sample of 600 nonpatients (Exner, 2001) is
probably representative. As such, it provides a reasonable basis to gain some un-
derstanding of the response rates for the coded features of responses. It also pro-
vides a source to identify the proportions of nonpatients that can be expected to
fall within, or outside of, established parameters for various ratios and other in-
dexes that form the core of structural data from which some interpretive princi-
ples have been developed.
402
TABLE 3
A Comparison of Data for 12 Variables for the Published Sample of 600 Nonpatients (Exner, 2001) and the First 175 Nonpatients Tested in
This Project
REFERENCES
APPENDIX
Initial Solicitation Letter
Hello,
Sometimes people who are interested in volunteering for a project such as this
hope to obtain feedback about their test performance. Unfortunately, the design of
this project prohibits us from doing this. Thus, the only way in which we are able to
show our appreciation of your assistance is through the donation made in your
name. Identification numbers will be used for all those who volunteer so that no
names will ever be entered on any of the test data collected.
If you are willing to volunteer for this project or if you have any questions about
volunteering, please contact me by phone at ___________________ (If you use e-
mail, you can also include your e-mail address.)
Sincerely,
Rorschach Workshops